Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression | stella

Back to Glioblastoma trials

Recruiting

Plain-English translation of NCT06936046 on ClinicalTrials.gov ↗ · Source last updated April 2025 · How we translate trials

Read our Glioblastoma research guide →

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

China

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou

Key details

Phase

Testing effectiveness

Sponsor

Second Affiliated Hospital, Zhejiang University, School of Medicine

Enrollment target

~200 participants

Started

January 2025

Primary completion

January 2027

Age range

18 Years and older

Last updated on clinicaltrials.gov in April 2025.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Ting Zhang

Second Affiliated Hospital, Zhejiang University, School of Medicine

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov